bone diseases
Collectively, we reveal that Ga13 is a master endogenous negative switch for osteoclastogenesis through regulation of the RhoA/Akt/GSK3b/NFATc1 signalling pathway, and that manipulating Ga13 activity might be a therapeutic strategy for bone diseases.